Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Mesalamine DR (Lialda) and balsalazide (Colazal) are both used to treat ulcerative colitis (UC), but they have some differences. Both medications belong to the same medication class called aminosalicylates and work by reducing inflammation in the gut. Mesalamine DR is a delayed-release tablet that is taken once a day with food, whereas, balsalazide is a capsule taken three times a day. Additionally, balsalazide can be taken with or without food, and its capsules can be opened and sprinkled on applesauce. Balsalazide may work better than mesalamine for UC flare-ups. Both medications can cause kidney and liver problems and a specific reaction called mesalamine-induced intolerance. Balsalazide can cause respiratory tract infections and joint pain, which is not common with mesalamine DR.
Mesalamine dr (Lialda)
Balsalazide (Colazal)
Mesalamine dr (Lialda)
Balsalazide (Colazal)
Summary of Lialda vs. Colazal
Summary for Aminosalicylate
Prescription only
Mesalamine DR (Lialda) is an aminosalicylate that's used to treat mild-to-moderate ulcerative colitis (UC) in adults and children. It's a delayed-release (DR) tablet that's taken by mouth once daily with food. Side effects aren't common but can include headache and stomach upset. Mesalamine DR (Lialda) also has a risk for serious skin rash and sensitivity to the sun (e.g., might sunburn more easily).
Summary for Aminosalicylate
Prescription only
Balsalazide disodium, also known by the brand name Colazal, is an aminosalicylate. It's a first-choice treatment option for treating mild-to-moderate ulcerative colitis (UC) in people age 5 years and older. Balsalazide (Colazal) is available as 750 mg capsules. The typical dosage for adults is 3 capsules by mouth three times per day. Children can take either 1 or 3 capsules by mouth three times per day. Side effects include stomach pain and diarrhea.